Free Trial

Raymond James Financial Inc. Takes $6.64 Million Position in Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare logo with Medical background

Raymond James Financial Inc. acquired a new stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 52,948 shares of the company's stock, valued at approximately $6,637,000. Raymond James Financial Inc. owned 0.29% of Addus HomeCare as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Smartleaf Asset Management LLC lifted its position in Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after acquiring an additional 214 shares during the last quarter. Parkside Financial Bank & Trust lifted its holdings in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after purchasing an additional 148 shares during the last quarter. Meeder Asset Management Inc. bought a new stake in Addus HomeCare in the 4th quarter valued at $77,000. Harvest Fund Management Co. Ltd acquired a new position in Addus HomeCare in the 4th quarter valued at $86,000. Finally, KBC Group NV increased its position in Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after buying an additional 268 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Oppenheimer upped their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. JMP Securities restated a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Tuesday. Macquarie reaffirmed an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a report on Thursday, February 27th. Stephens reaffirmed an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. Finally, StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Addus HomeCare has an average rating of "Buy" and a consensus price target of $139.00.

Check Out Our Latest Stock Report on Addus HomeCare

Addus HomeCare Price Performance

ADUS stock traded up $1.04 during trading on Friday, reaching $100.58. 97,408 shares of the company were exchanged, compared to its average volume of 162,804. The company has a market capitalization of $1.83 billion, a price-to-earnings ratio of 23.02, a P/E/G ratio of 1.41 and a beta of 0.93. The company has a 50-day moving average of $97.93 and a two-hundred day moving average of $116.06. Addus HomeCare Co. has a twelve month low of $88.96 and a twelve month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. On average, analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines